200 related articles for article (PubMed ID: 35798233)
21. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
Ahmed I; Teruya J; Murray-Krezan C; Krance R
Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
[TBL] [Abstract][Full Text] [Related]
22. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
[TBL] [Abstract][Full Text] [Related]
24. Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.
Sopfe J; Campbell K; Keating AK; Pyle L; Liu AK; Verneris MR; Giller RH; Forlenza GP
Pediatr Blood Cancer; 2020 Nov; 67(11):e28626. PubMed ID: 33480469
[TBL] [Abstract][Full Text] [Related]
25. Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations.
Youssef A; Hafez H; Madney Y; Elanany M; Hassanain O; Lehmann LE; El Haddad A
Pediatr Transplant; 2020 Feb; 24(1):e13610. PubMed ID: 31682054
[TBL] [Abstract][Full Text] [Related]
26. Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model.
Miller PDE; Forster AS; de Silva TI; Leonard H; Anthias C; Mayhew M; Klammer M; Paskar S; Hurst E; Peggs K; Madrigal A; Snowden JA
BMJ Open; 2018 Aug; 8(8):e021222. PubMed ID: 30093515
[TBL] [Abstract][Full Text] [Related]
27. Characterizing the cutaneous late effects of allogeneic hematopoietic stem cell transplantation: A systematic review.
Bourkas AN; Sibbald C; Chan AW; Schechter T; Ali M; Pullattayil AK; Levy R
Pediatr Transplant; 2024 Feb; 28(1):e14618. PubMed ID: 37786978
[TBL] [Abstract][Full Text] [Related]
28. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
[TBL] [Abstract][Full Text] [Related]
29. Severe sepsis in hematopoietic stem cell transplant recipients*.
Kumar G; Ahmad S; Taneja A; Patel J; Guddati AK; Nanchal R;
Crit Care Med; 2015 Feb; 43(2):411-21. PubMed ID: 25599465
[TBL] [Abstract][Full Text] [Related]
30. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
[TBL] [Abstract][Full Text] [Related]
31. Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients.
Cho S; Vigers T; Pyle L; Franklin A; Sopfe J; Jeney F; Forlenza G
Diabetes Technol Ther; 2023 Feb; 25(2):116-121. PubMed ID: 36511871
[No Abstract] [Full Text] [Related]
32. Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases.
Greco R; Snowden JA; Knelange NS; Tridello G; Cacciatore C; Xhaard A; Ciceri F; Collin M; Ferra C; De Becker A; Badoglio M; Averbuch D; Alexander T; Ljungman P; De la Camara R;
J Autoimmun; 2023 Apr; 136():103024. PubMed ID: 37001437
[TBL] [Abstract][Full Text] [Related]
33. Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children's hospital in Argentina.
Gomez SM; Caniza M; Fynn A; Vescina C; Ruiz CD; Iglesias D; Sosa F; Sung L
Transpl Infect Dis; 2018 Aug; 20(4):e12913. PubMed ID: 29679436
[TBL] [Abstract][Full Text] [Related]
34. Pediatric Acute Respiratory Distress Syndrome in Pediatric Allogeneic Hematopoietic Stem Cell Transplants: A Multicenter Study.
Rowan CM; Smith LS; Loomis A; McArthur J; Gertz SJ; Fitzgerald JC; Nitu ME; Moser EA; Hsing DD; Duncan CN; Mahadeo KM; Moffet J; Hall MW; Pinos EL; Tamburro RF; Cheifetz IM;
Pediatr Crit Care Med; 2017 Apr; 18(4):304-309. PubMed ID: 28178076
[TBL] [Abstract][Full Text] [Related]
35. Assessment of immune reconstitution status in recipients of a successful hematopoietic stem cell transplant from peripheral blood after reduced intensity conditioning.
Jaime-Pérez JC; Villarreal-Villarreal CD; Méndez-Ramírez N; Vázquez-Garza E; Salazar-Riojas R; Gómez-Almaguer D
Blood Cells Mol Dis; 2016 May; 58():52-6. PubMed ID: 27067489
[TBL] [Abstract][Full Text] [Related]
36. Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation.
Berro M; Arbelbide JA; Rivas MM; Basquiera AL; Ferini G; Vitriu A; Foncuberta C; Fernandez Escobar N; Requejo A; Milovic V; Yantorno S; Szelagoswki M; Martinez Rolon J; Bentolila G; Garcia JJ; Garcia P; Caeiro G; Castro M; Jaimovich G; Palmer S; Trucco JI; Bet LA; Shaw BE; Kusminsky GD
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1646-1650. PubMed ID: 28669923
[TBL] [Abstract][Full Text] [Related]
37. Surveillance and Outcomes of Pediatric Hematopoietic Stem Cell Transplantation Recipients During the Recent COVID-19 Outbreak in China.
Wang X; Yu U; Ding C; Ye H; Wang C; Yang C; Li Y; Zhou X; Zhang Q; Liu S; Wen F
Infect Drug Resist; 2023; 16():7455-7464. PubMed ID: 38089959
[TBL] [Abstract][Full Text] [Related]
38. Clinical presentation and outcomes of COVID-19 following hematopoietic cell transplantation and cellular therapy.
Camargo JF; Mendoza MA; Lin R; Moroz IV; Anderson AD; Morris MI; Natori Y; Natori A; Raja M; Lekakis L; Beitinjaneh A; Jimenez A; Goodman M; Wang T; Komanduri KV; Pereira D
Transpl Infect Dis; 2021 Aug; 23(4):e13625. PubMed ID: 33896088
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
[TBL] [Abstract][Full Text] [Related]
40. Late Effects in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation for Nonmalignant Diseases: Proxy- and Patient-Reported Outcomes.
Bense JE; Haverman L; von Asmuth EGJ; Louwerens M; Luijten MAJ; Stiggelbout AM; Lankester AC; de Pagter APJ
Transplant Cell Ther; 2023 Mar; 29(3):186.e1-186.e10. PubMed ID: 36587742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]